Article info
PDFOesophagus and Stomach
Research
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
- Correspondence to Professor Krish Ragunath MD FRCP FASGE, Professor & Head of GI Endoscopy, Nottingham Digestive Diseases Centre, NIHR Biomedical Research Unit, Queens Medical Centre campus, Nottingham University Hospitals NHS Trust, Nottingham NG7 2UH, UK; K.Ragunath@nottingham.ac.uk
Citation
Incidence of metachronous visible lesions in patients referred for radiofrequency ablation (RFA) therapy for early Barrett's neoplasia: a single-centre experience
Publication history
- Received January 7, 2015
- Revised February 5, 2015
- Accepted February 9, 2015
- First published March 13, 2015.
Online issue publication
April 19, 2016
Article Versions
- Previous version (19 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/